Abstract: The purpose of the present invention is to provide a copolymer having exceptional water permeability platelet adherence suppression and protein adherence suppression and to provide a separation membrane a medical device and a medical separation membrane module in which said copolymer is used. The present invention provides a copolymer containing monomer units derived from two or more types of monomer wherein the hydration energy density of the copolymer is 158.992 to 209.200 kJ·mol-1·nm-3 the monomer unit having the highest hydration energy density among the monomer units does not include a hydroxy group the volume fraction of monomer units having the highest hydration energy density among the monomer units is 35 to 90% and the difference in hydration energy density is 71.128 to 418.400 kJ·mol-1·nm-3.
1. A copolymer, comprising two or more types of monomer units,
wherein
a hydration energy density of the copolymer calculated based on the following Formula (1) is 158.992 to 209.200 kJ-mol^-nm"3,
a monomer unit with a highest hydration energy density of monomer unit i calculated based on the following Formula (2) is a monomer unit not containing a hydroxy group,
a volume fraction of a monomer unit with a highest hydration energy density of monomer unit i calculated based on the following Formula (3) is 35 to 90%,
a difference in hydration energy density calculated by the following Formula (4) is 71.128 to 418.400 kJ-mol^-nm"3,
Hydration energy density (kJ-moW-nm3) of copolymer =
Z • =1{(moIar fraction of monomer unit i) x (hydration energy of monomer unit i)}/
£N {(molar fraction of monomer unit i) x (volume of monomer unit i)} ■■-Formula (1),
wherein the hydration energy of monomer unit i is an absolute
value of a value obtained by subtracting energy in vacuum of monomer
unit i from energy in water of monomer unit i, N represents a total number
of monomer species constituting the copolymer, and i represents an
integer of 1 or more and N or less,
Hydration energy density (kJ-moW-nnr3) of monomer unit i = (hydration energy of monomer unit i)/( volume of monomer unit i) ■ ■ -Formula (2),
Volume fraction (%) of monomer unit with highest hydration energy density
of monomer unit i =
molar fraction of monomer unit with highest hydration energy density
of monomer unit i x
volume of monomer unit with highest hydration energy density of monomer unit i/
£j=1 {(molar fraction of monomer unit i) x (volume of monomer unit i)} —Formula (3),
wherein N and i are the same as defined above, and
Difference in hydration energy density (kJ-mol"Lnm"3) =
(hydration energy density of monomer unit with highest hydration energy density of monomer unit) - (hydration energy density of monomer unit with lowest hydration energy density of monomer unit) ■ ■ ■ Formula (4).
2. The copolymer according to claim 1, wherein
the hydration energy density of the copolymer is 167.360 to 200.832 kJ-mol^-nm"3,
the volume fraction of the monomer unit with the highest hydration energy density of monomer unit i is 40 to 80%, and
the difference in hydration energy density is 71.128 to 313.800 kJ-mol^-nm"3.
3. The copolymer according to claim 1 or 2, wherein the two or more types of monomer units comprise a hydrophobic monomer unit and a hydrophilic monomer unit.
4. The copolymer according to claim 3, wherein
the hydrophobic monomer unit is a repeating unit in a homopolymer or a copolymer obtained by polymerizing monomers selected from the group consisting of vinyl carboxylate, methacrylate, acrylate, and a styrene derivative, and
the hydrophilic monomer unit is a repeating unit in a homopolymer or a copolymer obtained by polymerizing monomers selected from the group consisting of an allylamine derivative, a vinylamine derivative, N-vinylamide, an acrylamide derivative, a methacrylamide derivative, N-vinyl lactam and N-acryloylmorpholine.
5. The copolymer according to claim 3 or 4, wherein
the hydrophobic monomer unit is a repeating unit in a homopolymer obtained by polymerizing vinyl carboxylate or a copolymer obtained by copolymerizing vinyl carboxylate, and
the hydrophilic monomer unit is a repeating unit in a homopolymer obtained by polymerizing N-vinyl lactam or a copolymer obtained by copolymerizing N-vinyl lactam.
6. A separation membrane, comprising the copolymer according to any one of claims 1 to 5.
7. A medical device, comprising the copolymer according to any one of claims 1 to 5.
8. A blood purifier, comprising the separation membrane according to claim 6.
| Section | Controller | Decision Date |
|---|---|---|
| # | Name | Date |
|---|---|---|
| 1 | 201947001586-RELEVANT DOCUMENTS [30-09-2023(online)].pdf | 2023-09-30 |
| 1 | 201947001586.pdf | 2019-01-14 |
| 2 | 201947001586-FER.pdf | 2021-10-17 |
| 2 | 201947001586-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [14-01-2019(online)].pdf | 2019-01-14 |
| 3 | 201947001586-US(14)-HearingNotice-(HearingDate-07-04-2021).pdf | 2021-10-17 |
| 3 | 201947001586-STATEMENT OF UNDERTAKING (FORM 3) [14-01-2019(online)].pdf | 2019-01-14 |
| 4 | 201947001586-PRIORITY DOCUMENTS [14-01-2019(online)].pdf | 2019-01-14 |
| 4 | 201947001586-IntimationOfGrant03-09-2021.pdf | 2021-09-03 |
| 5 | 201947001586-POWER OF AUTHORITY [14-01-2019(online)].pdf | 2019-01-14 |
| 5 | 201947001586-PatentCertificate03-09-2021.pdf | 2021-09-03 |
| 6 | 201947001586-FORM 3 [22-04-2021(online)].pdf | 2021-04-22 |
| 6 | 201947001586-FORM 1 [14-01-2019(online)].pdf | 2019-01-14 |
| 7 | 201947001586-Information under section 8(2) [22-04-2021(online)].pdf | 2021-04-22 |
| 7 | 201947001586-DRAWINGS [14-01-2019(online)].pdf | 2019-01-14 |
| 8 | 201947001586-Written submissions and relevant documents [22-04-2021(online)].pdf | 2021-04-22 |
| 8 | 201947001586-DECLARATION OF INVENTORSHIP (FORM 5) [14-01-2019(online)].pdf | 2019-01-14 |
| 9 | 201947001586-COMPLETE SPECIFICATION [14-01-2019(online)].pdf | 2019-01-14 |
| 9 | 201947001586-Correspondence to notify the Controller [05-04-2021(online)].pdf | 2021-04-05 |
| 10 | 201947001586-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [14-01-2019(online)].pdf | 2019-01-14 |
| 10 | 201947001586-FORM-26 [05-04-2021(online)].pdf | 2021-04-05 |
| 11 | 201947001586-CLAIMS [05-02-2021(online)].pdf | 2021-02-05 |
| 11 | abstract 201947001586.jpg | 2019-01-18 |
| 12 | 201947001586-FER_SER_REPLY [05-02-2021(online)].pdf | 2021-02-05 |
| 12 | 201947001586-Proof of Right (MANDATORY) [08-02-2019(online)].pdf | 2019-02-08 |
| 13 | 201947001586-FORM 3 [05-02-2021(online)].pdf | 2021-02-05 |
| 13 | Correspondence by Agent_Form-1_12-02-2019.pdf | 2019-02-12 |
| 14 | 201947001586-FORM 3 [13-06-2019(online)].pdf | 2019-06-13 |
| 14 | 201947001586-Information under section 8(2) [05-02-2021(online)].pdf | 2021-02-05 |
| 15 | 201947001586-FORM 3 [05-12-2019(online)].pdf | 2019-12-05 |
| 15 | 201947001586-OTHERS [05-02-2021(online)].pdf | 2021-02-05 |
| 16 | 201947001586-FORM 18 [03-04-2020(online)].pdf | 2020-04-03 |
| 17 | 201947001586-OTHERS [05-02-2021(online)].pdf | 2021-02-05 |
| 17 | 201947001586-FORM 3 [05-12-2019(online)].pdf | 2019-12-05 |
| 18 | 201947001586-Information under section 8(2) [05-02-2021(online)].pdf | 2021-02-05 |
| 18 | 201947001586-FORM 3 [13-06-2019(online)].pdf | 2019-06-13 |
| 19 | 201947001586-FORM 3 [05-02-2021(online)].pdf | 2021-02-05 |
| 19 | Correspondence by Agent_Form-1_12-02-2019.pdf | 2019-02-12 |
| 20 | 201947001586-FER_SER_REPLY [05-02-2021(online)].pdf | 2021-02-05 |
| 20 | 201947001586-Proof of Right (MANDATORY) [08-02-2019(online)].pdf | 2019-02-08 |
| 21 | 201947001586-CLAIMS [05-02-2021(online)].pdf | 2021-02-05 |
| 21 | abstract 201947001586.jpg | 2019-01-18 |
| 22 | 201947001586-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [14-01-2019(online)].pdf | 2019-01-14 |
| 22 | 201947001586-FORM-26 [05-04-2021(online)].pdf | 2021-04-05 |
| 23 | 201947001586-COMPLETE SPECIFICATION [14-01-2019(online)].pdf | 2019-01-14 |
| 23 | 201947001586-Correspondence to notify the Controller [05-04-2021(online)].pdf | 2021-04-05 |
| 24 | 201947001586-Written submissions and relevant documents [22-04-2021(online)].pdf | 2021-04-22 |
| 24 | 201947001586-DECLARATION OF INVENTORSHIP (FORM 5) [14-01-2019(online)].pdf | 2019-01-14 |
| 25 | 201947001586-Information under section 8(2) [22-04-2021(online)].pdf | 2021-04-22 |
| 25 | 201947001586-DRAWINGS [14-01-2019(online)].pdf | 2019-01-14 |
| 26 | 201947001586-FORM 3 [22-04-2021(online)].pdf | 2021-04-22 |
| 26 | 201947001586-FORM 1 [14-01-2019(online)].pdf | 2019-01-14 |
| 27 | 201947001586-POWER OF AUTHORITY [14-01-2019(online)].pdf | 2019-01-14 |
| 27 | 201947001586-PatentCertificate03-09-2021.pdf | 2021-09-03 |
| 28 | 201947001586-PRIORITY DOCUMENTS [14-01-2019(online)].pdf | 2019-01-14 |
| 28 | 201947001586-IntimationOfGrant03-09-2021.pdf | 2021-09-03 |
| 29 | 201947001586-US(14)-HearingNotice-(HearingDate-07-04-2021).pdf | 2021-10-17 |
| 29 | 201947001586-STATEMENT OF UNDERTAKING (FORM 3) [14-01-2019(online)].pdf | 2019-01-14 |
| 30 | 201947001586-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [14-01-2019(online)].pdf | 2019-01-14 |
| 30 | 201947001586-FER.pdf | 2021-10-17 |
| 31 | 201947001586-RELEVANT DOCUMENTS [30-09-2023(online)].pdf | 2023-09-30 |
| 31 | 201947001586.pdf | 2019-01-14 |
| 1 | searchstrategyE_26-08-2020.pdf |